Related Experiment Video
Updated: Jan 31, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a)
Elisa Waldmann1, Klaus G Parhofer1
1Medical Department IV - Grosshadern, University Munich, Munich, Germany.
Lipoprotein apheresis effectively lowers low-density lipoprotein cholesterol (LDL-c) and lipoprotein(a) [Lp(a)] when standard treatments fail. This cardiovascular risk reduction method, while effective, requires further randomized controlled trials for definitive clinical benefit evidence.
Area of Science:
- Cardiology
- Lipidology
- Cardiovascular Medicine
Background:
- Low-density lipoprotein cholesterol (LDL-c) and lipoprotein(a) [Lp(a)] are independent cardiovascular risk factors.
- Standard treatments like lifestyle modification and medications often fail to achieve guideline-defined goals for LDL-c and Lp(a) reduction.
- Current drugs lack efficiency in lowering Lp(a) or demonstrating clinical benefit from Lp(a) reduction.
Purpose of the Study:
- To evaluate the efficacy of lipoprotein apheresis in reducing LDL-c and Lp(a) levels in patients unresponsive to standard therapies.
- To review the various apheresis systems available and their impact on lipid profiles.
- To discuss the tolerability, cost, and limitations of evidence for lipoprotein apheresis.
Main Methods:
- Review of existing literature on lipoprotein apheresis systems (e.g., HELP, DALI, dextran sulfate, lipid filtration, immunoadsorption).
- Analysis of the impact of apheresis on LDL-c and Lp(a) levels, including reduction percentages per session and mean interval concentrations.
- Discussion of Lipopac as a specific immunapheresis targeting Lp(a).
Main Results:
- Lipoprotein apheresis significantly decreases LDL-c and Lp(a) by approximately 65% per session.
- Weekly or biweekly apheresis results in approximately 30% reduction in mean interval concentrations.
- Most apheresis systems reduce both LDL-c and Lp(a), with Lipopac specifically targeting Lp(a).
Conclusions:
- Lipoprotein apheresis is a highly effective treatment for reducing LDL-c and Lp(a) in patients who do not reach treatment goals with standard therapies.
- While well-tolerated, lipoprotein apheresis is costly and time-consuming.
- Current evidence for clinical benefit is primarily observational, highlighting the need for randomized controlled trials.
Related Concept Videos
Freezing Point Depression and Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
Elevation of Intermediate Points on Vertical Curves
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Receptor-mediated Endocytosis
Global Climate Change
Social Scripts

